CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer von Mostafid, AH, Porta, N, Cresswell, J, Griffiths, TRL, Kelly, JD, Penegar, SR, Davenport, K, McGrath, JS, Campain, N, Cooke, P, Masood, S, Knowles, MA, Feber, A, Knight, A, Catto, JWF, Lewis, R, Hall, E

Volltext bestellen

CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer von Mostafid, AH, Porta, N, Cresswell, J, Griffiths, T, Kelly, JD, Penegar, SR, Davenport, K, McGrath, JS, Campain, N, Cooke, P, Masood, S, Knowles, MA, Feber, A, Knight, A, Catto, JW, Lewis, R, Hall, E

Volltext bestellen